ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Health Technology

Japan Lifeline Co., Ltd.

Business Summary

Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. Its products include cardiac rhythm devices, electrophysiology and ablation catheters, cardiovascular surgery devices, transvascular intervention, and blood purification related products. The company was founded on February 6, 1981 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue51,761M476.06M
Gross Profit28,718M264.13M
Operating income10,435M95.97M
Income before tax10,425M95.88M
Net income7,748M71.26M
EBITDA11,896M109.41M
Diluted EPS96.540.88
Dividends Per Share290.26
Total Assets75,055M695.24M
Total liabilities23,645M219.02M
Total equity51,406M476.17M
Operating cash flow7,096M65.26M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 30,540M 37,181M 42,298M 45,525M 51,761M
Gross Profit 16,866M 21,564M 26,164M 27,286M 28,718M
Operating income 3,700M 7,686M 10,672M 10,527M 10,435M
Income before tax 4,514M 7,957M 10,615M 10,801M 10,425M
Net income 2,804M 5,350M 7,478M 7,723M 7,748M
EBITDA 4,694M 8,646M 11,767M 11,785M 11,896M
Diluted EPS 36.69 71.89 98.43 95.85 96.54
Dividends Per Share 6.25 15 28.75 29 29
Total Assets 36,165M 40,427M 60,980M 67,783M 75,055M
Total liabilities 20,275M 19,675M 19,888M 21,286M 23,645M
Total equity 15,890M 20,750M 41,090M 46,493M 51,406M
Operating cash flow 916M 6,584M 4,450M 7,037M 7,096M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 254.32M 343.35M 381.63M 410.52M 476.06M
Gross Profit 140.45M 199.13M 236.06M 246.05M 264.13M
Operating income 30.81M 70.97M 96.28M 94.92M 95.97M
Income before tax 37.59M 73.48M 95.77M 97.39M 95.88M
Net income 23.35M 49.40M 67.47M 69.64M 71.26M
EBITDA 39.08M 79.84M 106.16M 106.27M 109.41M
Diluted EPS 0.30 0.66 0.88 0.86 0.88
Dividends Per Share 0.05 0.13 0.25 0.26 0.26
Total Assets 321.76M 362.80M 573.38M 612.39M 695.24M
Total liabilities 180.39M 176.56M 187.00M 192.31M 219.02M
Total equity 141.37M 186.21M 386.36M 420.04M 476.17M
Operating cash flow 7.62M 60.80M 40.15M 63.45M 65.26M

Valuation Measures

Mar 2020
PER14.10
ROA10.84%
ROE15.82%
Operating margin20.15%
Profit margin14.96%

Key executives

  • President & Representative Director: Keisuke Suzuki
  • Manager-Accounting & Finance: Takeshi Egawa
  • MD, GM-Development Production & Manager-Technology: Shogo Takahashi
  • Senior Manager-Research & Development: Kenji Mori
  • Representative Director, VP & Head-Administration: Atsuhiro Suzuki

Shareholders

  • SUZUKI KEISUKE /JAPAN LIFELINE/ (13.0%)
  • MASUMOTO TAKESHI /JAPAN LIFELINE/ (11.5%)
  • Sompo Asset Management Co., Ltd. (5.7%)
  • Japan Lifeline Co., Ltd. (5.7%)
  • Nomura Asset Management Co., Ltd. (3.1%)
  • The Vanguard Group, Inc. (2.3%)
  • Grandeur Peak Global Advisors LLC (1.3%)
  • Norges Bank Investment Management (1.3%)
  • Japan Lifeline Employee Stock Ownership Plan (1.2%)
  • APG Asset Management NV (1.0%)

Contact Details

  • Website:http://www.jll.co.jp
  • Address: Tennozu Ocean Square, 25/F, 2-2-20 Higashi-Shinagawa, Tokyo, 140-0002, Japan
  • Phone: +81.3.6711.5200

Related Companies

  • Japan Lifeline Employee Incentive Plan
  • Japan Lifeline Board Incentive Plan
  • Junken Medical Co. Ltd.
  • UBE Juken KK
  • Cardiac Rhythm Management
  • Sorin Group Japan Co. Ltd.
  • Japan Lifeline Employee Stock Ownership Plan

Competitors

    Last Updated on 25 Sep, 2020

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Try 1 month for $0.99

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

    This is your last free article this month

    Stay ahead with our exclusives on Asia; the most
    dynamic market in the world
    .

    Get trusted insights from experts
    within Asia itself.

    Try 3 months for $9

    Offer ends July 31st

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to the Nikkei Asian Review has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media